Subsequently, the low expression of NFAT5 could up-regulate aspartyl-tRNA synthetase 2 (DARS2), thereby promoting liver cancer development by accelerating cell cycle progression and inhibiting cell apoptosis. Here, NFAT5 is linked to liver cancer.